Skip to content

Self-directed Versus Therapist-directed Re-loading on Incidence of Ulcer Recurrence

The Effect of Self-directed Versus Therapist-directed Re-loading on Incidence of Ulcer Recurrence

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04310137
Enrollment
30
Registered
2020-03-17
Start date
2021-05-01
Completion date
2023-12-31
Last updated
2021-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Foot Ulcer

Keywords

Diabetes, re-loading, ulcer recurrence

Brief summary

This study is designed to evaluate if how people are told to return to walking after a skin injury affects whether or not they develop new (recurrence) skin breakdown on their feet. The people in this study will have diabetes and have a recently closed foot ulcer. About half will be specifically told how to return to walking and the other half will be told to return to walking slowly. How people naturally return to walking will also be established.

Detailed description

The purpose of this project is to determine the impact of Therapist-directed loading versus self-selected loading on ulcer occurrence and to establish natural loading behavior following diabetic foot ulcer closure. Eligible participants will be randomized into a group given specific directions from a Therapist to return to walking (i.e. reloading skin following plantar ulceration closure) or a group encouraged to slowly return to walking (self-directed re-loading of the skin following plantar ulceration closure). Following randomization and instruction for re-loading according to group assignment, participants will be assessed every 6 months for walking behavior. Participants will be monitored for ulcer recurrence throughout. Participants will be followed for up to 18 months.

Interventions

BEHAVIORALTherapist-Directed Re-loading

Therapist will specifically direct participant to increase walking by 10% as measured at each of the activity monitoring assessments. In addition, the participant will be asked to monitor foot temperature to mitigate risk for breakdown.

Sponsors

Mercer University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Masking description

The outcome assessor will be unaware of in which group the participant was randomized.

Intervention model description

Randomized Controlled Trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* With or without peripheral neuropathy * Able to safely exercise * Have a recently closed plantar ulceration

Exclusion criteria

* Presence of an open plantar ulceration * Presence of an untreated infection * Presence of osteomyelitis or gangrene

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Ulcer RecurrenceOver up to 18 months of follow-up.Assessment of incidence of any plantarr ulcer recurrence.
Change in walking behavior (steps)Assessed initially and every 6 months for 1 week for up to 18 months.Actual assessment of change in walking behavior will be assessed by number of steps.
Change in walking behavior (step timing)Assessed initially and every 6 months for 1 week for up to 18 months.Actual assessment of change in walking behavior will be assessed by the timing of steps (how many steps in a given timeframe).

Secondary

MeasureTime frameDescription
Exercise component of Summary of Diabetes Self-Care Activities ScaleAssessed initially and every 6 months for up to 18 monthsQuestionnaire to assess exercise adherence. It is a report of the number of days that an individual participates in physical activity as well as specific exercise (2 questions). The higher the number, the more days of activity/exercise participation. The more days of participation, the better the investigators would expect health to be.
Waist circumferenceAssessed initially and every 6 months for up to 18 monthsWaist circumference (measured in cm) will be assessed for change over time.
Bio-thesiometerAssessed initially and every 6 months for up to 18 monthsAssesses vibration sense
Body Mass Index (BMI) and disease riskAssessed initially and every 6 months for up to 18 monthsWeight and height will be combined to report BMI in kg/m\^2.

Countries

United States

Contacts

Primary ContactDeborah M. Wendland, PhD
wendland_dm@mercer.edu6785476775
Backup ContactTeri Biven, DPT
teri.biven@piedmont.org404.605.2743

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026